OSMOPHARM SA - SWITZERLANDTJOAPACK NETHERLANDS B.V (PRIMARY PACKAGER) (NETHERLANDS)🇸🇬 Health Sciences Authority
Approval Date
Jan 7, 1991
Approval ID
0278326b929d8e96
Company
OSMOPHARM SA - SWITZERLANDTJOAPACK NETHERLANDS B.V (PRIMARY PACKAGER) (NETHERLANDS)
Type
Therapeutic
Approval Details
Approval Id
0278326b929d8e96
Drug Name
PANBESY CAPSULE 15 MG
Product Name
PANBESY CAPSULE 15 MG
Approval Number
SIN05315P
Approval Date
1991-01-07
Registrant
EURODRUG LABORATORIES SINGAPORE PTE. LTD.
Licence Holder
EURODRUG LABORATORIES SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Dosage
<p><strong>RECOMMENDED DOSAGE</strong><br>
Adult: 1–2 capsules of 15 mg a day before breakfast.<br>
Adult: 1 capsule of 30 mg a day before breakfast.</p>
Route Of Administration
ORAL
Indication Info
<p><strong>INDICATIONS</strong><br>
For short term use as an adjunct to the treatment of some patients with moderate to severe obesity.</p>
Contraindications
<p><strong>CONTRAINDICATIONS</strong><br>
Epilepsy; hypersensitivity to sympathomimetic amines; advanced arteriosclerosis; severe hypertension; children under 12 years; hyperexcitability; patients with cardiovascular disease; hyperthyroidism; glaucoma.<br>
Patients with a history of drug abuse. During or 14 days following administration of monoamine oxidase inhibitors.</p>
